|
2025
|
Invention
|
Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof.
One aspect of the ... |
|
2023
|
Invention
|
Metap2 inhibitors for the treatment of prostate cancer. The present disclosure provides pharmaceu... |
|
|
Invention
|
Metap2 inhibitors for the treatment of prostate cancer |
|
|
Invention
|
Metap2 inhibitors for the treatment of pulmonary fibrosis. The present disclosure provides pharma... |
|
|
Invention
|
Metap2 inhibitors for the treatment of pulmonary fibrosis |
|
|
G/S
|
Providing information about clinical trials for pharmaceutical preparations Provision of medical ... |
|
|
Invention
|
Combinations comprising metap2 inhibitors for the treatment of cancer. The present disclosure pro... |
|
|
Invention
|
Biomarkers of metap2 inhibitors and applications thereof. The present disclosure relates to modif... |
|
2022
|
Invention
|
Treatment for tumors driven by metabolic dysfuction.
The present disclosure relates to modified ... |
|
|
Invention
|
Metap2 inhibitors and methods of treating obesity.
The present invention relates to modified or ... |
|
2021
|
Invention
|
Combinations of metap2 inhibitors and cd4/6 inhibitors for the treatment of cancer.
The present ... |
|
|
Invention
|
Combinations of metap2 inhibitors and cdk4/6 inhibitors for the treatment of cancer. The present ... |
|
2020
|
Invention
|
Treatment for tumors driven by metabolic dysfunction. The present disclosure relates to modified ... |
|
|
Invention
|
Metap2 inhibitors and methods of treating obesity. The present invention relates to modified or p... |
|
2019
|
Invention
|
Biomarkers of metap2 inhibitors and applications thereof. The present disclosure relates to small... |
|
2018
|
Invention
|
Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof. One aspect of the i... |
|
|
Invention
|
Fumagillol derivatives and polymorphs thereof. The present disclosure relates to salts and polymo... |
|
2017
|
G/S
|
Pharmaceutical preparations for the treatment of cancer and metabolic disorders, namely hyperinsu... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer and
metabolic disorders. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer and metabolic disorders |
|
|
Invention
|
Treatment for tumors driven by metabolic dysfunction.
The present disclosure provides ... |
|
|
Invention
|
Treatment for tumors driven by metabolic dysfunction. The present disclosure provides metho... |
|
2014
|
Invention
|
Optimized drug conjugates.
The invention generally relates to optimized drug conjugates. |
|
2011
|
Invention
|
Optimized drug conjugates. Optimized drug conjugates, wherein the active moiety is modified and a... |
|
2007
|
G/S
|
[ Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharma... |
